Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1998 1
2003 1
2004 2
2005 2
2006 3
2007 2
2009 1
2010 3
2011 13
2012 12
2013 10
2014 4
2015 8
2016 10
2017 7
2018 6
2019 10
2020 8
2021 17
2022 9
2023 4
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

121 results

Results by year

Filters applied: . Clear all
Page 1
A first-in-human study of the anti-LAG-3 antibody favezelimab plus pembrolizumab in previously treated, advanced microsatellite stable colorectal cancer.
Garralda E, Sukari A, Lakhani NJ, Patnaik A, Lou Y, Im SA, Golan T, Geva R, Wermke M, de Miguel M, Palcza J, Jha S, Chaney M, Abraham AK, Healy J, Falchook GS. Garralda E, et al. Among authors: sukari a. ESMO Open. 2022 Dec;7(6):100639. doi: 10.1016/j.esmoop.2022.100639. Epub 2022 Dec 6. ESMO Open. 2022. PMID: 36493599 Free PMC article.
A user's guide to lorlatinib.
Nagasaka M, Ge Y, Sukari A, Kukreja G, Ou SI. Nagasaka M, et al. Among authors: sukari a. Crit Rev Oncol Hematol. 2020 Jul;151:102969. doi: 10.1016/j.critrevonc.2020.102969. Epub 2020 May 11. Crit Rev Oncol Hematol. 2020. PMID: 32416346 Free article. Review.
Cancer Immunology and Immunotherapy.
Sukari A, Nagasaka M, Al-Hadidi A, Lum LG. Sukari A, et al. Anticancer Res. 2016 Nov;36(11):5593-5606. doi: 10.21873/anticanres.11144. Anticancer Res. 2016. PMID: 27793882 Review.
Biomarkers predictive of response to pembrolizumab in head and neck cancer.
Pfister DG, Haddad RI, Worden FP, Weiss J, Mehra R, Chow LQM, Liu SV, Kang H, Saba NF, Wirth LJ, Sukari A, Massarelli E, Ayers M, Albright A, Webber AL, Mogg R, Lunceford J, Huang L, Cristescu R, Cheng J, Seiwert TY, Bauml JM. Pfister DG, et al. Among authors: sukari a. Cancer Med. 2023 Mar;12(6):6603-6614. doi: 10.1002/cam4.5434. Epub 2022 Dec 7. Cancer Med. 2023. PMID: 36479637 Free PMC article.
p16 positive oropharyngeal small cell cancer: A case report.
Al Masalmeh N, Kukreja G, Zaiem F, Raza SN, Kim H, Nagasaka M, Sukari A. Al Masalmeh N, et al. Among authors: sukari a. Oral Oncol. 2021 Oct;121:105391. doi: 10.1016/j.oraloncology.2021.105391. Epub 2021 Jun 27. Oral Oncol. 2021. PMID: 34187735
121 results